ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

MYC/TET3-Regulated TMEM65 Activates OXPHOS-SERPINB3 Pathway to Promote Progression and Cisplatin Resistance in Triple-Negative Breast Cancer.

Yin-Ling Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.